Autolus Therapeutics
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Autolus Therapeutics's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 73% to $1,698,000. Profit margin reached -12272%. Total operating expenses were $1,698,000.
Profit Margin
| 2015 | 94.11K | -7.46M | -7931.14% |
|---|---|---|---|
| 2016 | 1.21M | -12.55M | -1035.48% |
| 2017 | 1.69M | -19.72M | -1165.21% |
| 2018 | 1.04M | -31.11M | -2976.49% |
| 2019 | 2.90M | -123.84M | -4258.91% |
| 2020 | 242K | -142.09M | -58716.53% |
| 2021 | 2.33M | -142.09M | -6098.54% |
| 2022 | 6.19M | -148.83M | -2402.95% |
| 2023 | 1.69M | -208.38M | -12272.26% |
AUTL Income Statement (2015 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|
Revenue | |||||||||
Revenue | 1.69M | 6.19M | 2.33M | 242K | 2.90M | 1.04M | 1.69M | 1.21M | 94.11K |
Cost of revenue | 6.56M | 137.22M | 128.65M | 134.88M | 4.61M | 48.29M | 1.00M | 0 | 0 |
Gross profit | -4.86M | -131.02M | -126.32M | -134.64M | -1.70M | -47.25M | 684.00K | 1.21M | 94.11K |
Operating exp. | |||||||||
Research and development | 149.98M | 141.99M | 134.78M | 134.88M | 105.41M | 24.63M | 16.01M | 10.43M | 2.17M |
Selling and marketing | 1.09M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 1.69M | 173.72M | 166.65M | 168.38M | 144.87M | 41.48M | 25.11M | 15.58M | 8.20M |
Operating income | -195.02M | -163.78M | -164.20M | -168.14M | -137.86M | -57.53M | -23.41M | -14.37M | -8.10M |
Other income (expenses), net | -13.37M | -9.42M | -1.78M | 1.88M | -1.14M | 3.97M | 38K | -26K | 7.92K |
Income before tax | -208.40M | -173.20M | -165.98M | -166.25M | -139.00M | -36.32M | -23.38M | -14.32M | -8.09M |
Income tax expense | -19K | -24.36M | -23.89M | -24.16M | -15.15M | -5.21M | -3.65M | -1.77M | 634.50K |
Net income | -208.38M | -148.83M | -142.09M | -142.09M | -123.84M | -31.11M | -19.72M | -12.55M | -7.46M |
Earnings per share | |||||||||
Basic EPS | -1.2 | -1.57 | -1.97 | -2.76 | -2.88 | -0.99 | -1.43 | -0.91 | -0.54 |
Diluted EPS | -1.2 | -1.57 | -1.97 | -2.76 | -2.88 | -0.99 | -1.43 | -0.91 | -0.54 |
| Data source | Data source | Data source | Data source | Data source | Data source |